Literature DB >> 35081681

The immune-modulating effects of viable Weissella cibaria JW15 on RAW 264.7 macrophage cells.

Ho-Eun Park1, Kyung-Hyo Do1, Wan-Kyu Lee1.   

Abstract

The objective of this study is to investigate the immune-enhancing ability of viable and heat-killed Weissella cibaria JW15 (JW15) isolated from Kimchi in RAW 264.7 macrophages. The immune effects were evaluated by measuring the production of NO, cytokines, inflammatory enzyme, and activation of NF-κB. Viable JW15 executed higher activity on stimulating the release of TNF-α as well as activating NF-κB compared to that of heat-killed JW15. Additionally, viable and heat-killed JW15 significantly increased the production of NO, IL-6 and TNF-α more than that of Lactobacillus rhamnosus GG (LGG). Furthermore, viable JW15 induced higher production of iNOS compared with that of viable LGG. Collectively, our finding indicates that viable JW15 had similar, if not more, immune-enhancing activities as heat-killed JW15. In addition, viable JW15 had higher immune-enhancing activity than commercial strain LGG. Therefore, viable JW15 has the potential to be used as a functional food to improve the host immune response.

Entities:  

Keywords:  Weissella cibaria JW15; heat-killed probiotics; immune-enhancing effect; probiotics; viable probiotics

Year:  2019        PMID: 35081681      PMCID: PMC7007729          DOI: 10.7555/JBR.33.20190095

Source DB:  PubMed          Journal:  J Biomed Res        ISSN: 1674-8301


  30 in total

1.  Lactobacillus sakei K040706 evokes immunostimulatory effects on macrophages through TLR 2-mediated activation.

Authors:  Ji-Yun Jung; Ji-Sun Shin; Suel-Gie Lee; Young Kyoung Rhee; Chang-Won Cho; Hee-Do Hong; Kyung-Tae Lee
Journal:  Int Immunopharmacol       Date:  2015-06-03       Impact factor: 4.932

Review 2.  Nitric oxide synthase structure and mechanism.

Authors:  M A Marletta
Journal:  J Biol Chem       Date:  1993-06-15       Impact factor: 5.157

3.  Lipoteichoic acids from Lactobacillus strains elicit strong tumor necrosis factor alpha-inducing activities in macrophages through Toll-like receptor 2.

Authors:  Tetsuya Matsuguchi; Akimitsu Takagi; Takeshi Matsuzaki; Masato Nagaoka; Kimika Ishikawa; Teruo Yokokura; Yasunobu Yoshikai
Journal:  Clin Diagn Lab Immunol       Date:  2003-03

4.  Lipoteichoic Acid Isolated from Weissella cibaria Increases Cytokine Production in Human Monocyte-Like THP-1 Cells and Mouse Splenocytes.

Authors:  Yi-Fan Hong; Yoon-Doo Lee; Jae-Yeon Park; Seongjae Kim; Youn-Woo Lee; Boram Jeon; Deepa Jagdish; Hangeun Kim; Dae Kyun Chung
Journal:  J Microbiol Biotechnol       Date:  2016-07-28       Impact factor: 2.351

5.  Immunomodulatory Potential of Weissella cibaria in Aged C57BL/6J Mice.

Authors:  Ho-Eun Park; Kyung-Won Kang; Bum-Seok Kim; Sang-Myeong Lee; Wan-Kyu Lee
Journal:  J Microbiol Biotechnol       Date:  2017-12-28       Impact factor: 2.351

Review 6.  Beneficial effects of lactic acid bacteria on human beings.

Authors:  Muhammad Irfan Masood; Muhammad Imran Qadir; Jafir Hussain Shirazi; Ikram Ullah Khan
Journal:  Crit Rev Microbiol       Date:  2010-12-17       Impact factor: 7.624

7.  Weissellicin 110, a newly discovered bacteriocin from Weissella cibaria 110, isolated from plaa-som, a fermented fish product from Thailand.

Authors:  Sirinat Srionnual; Fujitoshi Yanagida; Li-Hsiu Lin; Kuang-Nan Hsiao; Yi-sheng Chen
Journal:  Appl Environ Microbiol       Date:  2007-02-09       Impact factor: 4.792

Review 8.  Probiotics in man and animals.

Authors:  R Fuller
Journal:  J Appl Bacteriol       Date:  1989-05

9.  Weissella beninensis sp. nov., a motile lactic acid bacterium from submerged cassava fermentations, and emended description of the genus Weissella.

Authors:  Sègla Wilfrid Padonou; Ulrich Schillinger; Dennis S Nielsen; Charles M A P Franz; Michael Hansen; Joseph D Hounhouigan; Mathurin C Nago; Mogens Jakobsen
Journal:  Int J Syst Evol Microbiol       Date:  2009-11-06       Impact factor: 2.747

10.  In vitro study of the effect of a probiotic bacterium Lactobacillus rhamnosus against herpes simplex virus type 1.

Authors:  Soghra Khani; Mohammad Motamedifar; Hossein Golmoghaddam; Hamideh Mahmoodzadeh Hosseini; Zahra Hashemizadeh
Journal:  Braz J Infect Dis       Date:  2012 Mar-Apr       Impact factor: 1.949

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.